SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Response Biomedical (V.RBM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dick Martin who wrote (381)2/14/2001 10:19:00 AM
From: Starowl  Read Replies (1) of 655
 
Dick, this is the first milestone in the list made public last month, the beta/pre-clinical tests. Next milestone is completion of the clinical tests next month. We shall see if the company is able to meet that one.

"(Jan) "One of the single most important tasks facing me [Radvak] is to regain your confidence and the confidence of the investment community at large. The road to recovery begins with openness and honesty. We will show exactly where we stand, and exactly where we are going. After conducting an in-depth review of the program prior to accepting this position, I am confident that the technology now stands on its own merit and that timelines will be met.

"Here are the upcoming milestones, the achievement of which will add immense value to the Company and its shareholders, by providing independent validation of the technology:

· Myoglobin Test and RAMP Reader in Beta Testing January 2001
· Myoglobin Test and RAMP Reader in Clinical Trials March 2001
· Myoglobin Test and RAMP Reader FDA Submission June 2001
· Myoglobin Test and RAMP Reader FDA Clearance Sept. 2001 (expected)
· Troponin I and CK-MB Test FDA Submission March 2002"
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext